92P Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study
Annals of Oncology(2022)
Key words
hepatocellular carcinoma,bevacizumab treatment,liver resection,macrovascular invasion,atezolizumab,pre-specified
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined